Joint Formulary & PAD

Non-Clinical Profile : Controlled drugs

Non-Clinical Profile

Keywords :
Tramadol, Lisdexamfetamine, Zopiclone, Zaleplon, CDs, opioids, opiates, hypnotics, anxiolytics, gabapentinoids, pain, opioid analgesics, opioid analgesia, special patient notes, SPNs, requests for urgent supply, drug seeking behaviour, CD safety, drug misuse,
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
16

Committee Recommendations (3)

The Medicines Safety Committee have agreed to adopt NHSE Controlled Drug guidance documents for primary care including:
 - Controlled Drugs On Discharge
 - Multi-Professional Prescribing (Mpp) In Primary Care- Controlled Drugs
 - Preventing Prescription Fraud In Your Surgery
 - Repeat Prescribing Of Controlled Drugs
 - Reporting Controlled Drug Incidents & Concerns
 - Requests For Controlled Drugs

02 Dec 20 - Not Set

Controlled Drug resource pack for General Practice:

This educational and resource pack brings together helpful resources that primary care teams can use within their practice.  It aims to support the appropriate use and review of controlled drug prescribing in Surrey Heartlands.

A number of additional resources, including patient information leaflets can also be found below

Please also note that our local guidance document “The Pharmacological Management of Persistent Non-Malignant Pain in Adults” is on PAD and contains additional resources (https://surreyccg.res-systems.net/PAD/Guidelines/Detail/6095)

The Royal Pharmaceutical Society announced changes to Controlled Drug Legislation which take effect from Tuesday 10th June 2014. The changes affect tramadol, lisdexamfetamine, zopiclone and zaleplon. The requirements for prescription writing and storage can be found in the summary document below